| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Director | Common Stock | 21,067 | $1,600,249 | $75.96 | 02 Jan 2026 | Direct |
| BICYCLE THERAPEUTICS PLC | Chief Financial Officer | Ordinary Shares | 87,081 | $569,509 | $6.54 | 05 Jan 2026 | Direct |
| Pacira BioSciences, Inc. | Director | Stock Option (Right to Buy) | 11,279 | $323,840 | $26.59 | 11 Jun 2025 | Direct |
| Pacira BioSciences, Inc. | Director | Common Stock | 11,393 | $286,192 | $25.12 | 11 Jun 2025 | Direct |
| PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 3,475 | $238,040 | $27.05 | 02 Jan 2026 | Direct |
| Graphite Bio, Inc. | Chief Financial Officer | Stock Option (right to buy) | 220,000 | 21 Feb 2023 | Direct | ||
| BICYCLE THERAPEUTICS PLC | Chief Financial Officer | Employee Stock Option (right to buy) | 100,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCYC | BICYCLE THERAPEUTICS PLC | 02 Jan 2026 | 5 | -$50,489 | 4 | Chief Financial Officer | 06 Jan 2026, 20:00 |
| PTCT | PTC THERAPEUTICS, INC. | 02 Jan 2026 | 2 | $0 | 4 | Director | 06 Jan 2026, 17:20 |
| BCYC | BICYCLE THERAPEUTICS PLC | 02 Oct 2025 | 2 | -$4,103 | 4 | Chief Financial Officer | 06 Oct 2025, 16:45 |
| BCYC | BICYCLE THERAPEUTICS PLC | 02 Jul 2025 | 1 | -$1,446 | 4 | Chief Financial Officer | 07 Jul 2025, 17:20 |
| PCRX | Pacira BioSciences, Inc. | 11 Jun 2025 | 2 | $0 | 4 | Director | 13 Jun 2025, 16:17 |
| BCYC | BICYCLE THERAPEUTICS PLC | 02 Apr 2025 | 1 | -$1,724 | 4 | Chief Financial Officer | 04 Apr 2025, 17:35 |
| PTCT | PTC THERAPEUTICS, INC. | 03 Jan 2025 | 2 | $0 | 4 | Director | 07 Jan 2025, 17:20 |
| BCYC | BICYCLE THERAPEUTICS PLC | 02 Jan 2025 | 3 | -$19,656 | 4 | Chief Financial Officer | 06 Jan 2025, 19:30 |
| PCRX | Pacira BioSciences, Inc. | 12 Jun 2024 | 2 | $0 | 4 | Director | 13 Jun 2024, 18:13 |
| PTCT | PTC THERAPEUTICS, INC. | 15 Feb 2024 | 2 | $0 | 4 | Director | 16 Feb 2024, 16:10 |
| BCYC | BICYCLE THERAPEUTICS plc | 02 Jan 2024 | 2 | $0 | 4 | Chief Financial Officer | 04 Jan 2024, 18:27 |
| PCRX | Pacira BioSciences, Inc. | 06 Oct 2023 | 1 | $0 | 4 | Director | 11 Oct 2023, 16:47 |
| PCRX | Pacira BioSciences, Inc. | 06 Oct 2023 | 0 | $0 | 3 | Director | 11 Oct 2023, 16:43 |
| PTCT | PTC THERAPEUTICS, INC. | 06 Sep 2023 | 6 | -$464,972 | 4 | Director | 08 Sep 2023, 16:02 |
| BCYC | BICYCLE THERAPEUTICS plc | 17 Jul 2023 | 1 | $0 | 4 | Chief Financial Officer | 19 Jul 2023, 18:23 |
| BCYC | BICYCLE THERAPEUTICS plc | 17 Jul 2023 | 0 | $0 | 3 | Chief Financial Officer | 19 Jul 2023, 18:20 |
| GRPH | Graphite Bio, Inc. | 21 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 23 Feb 2023, 16:04 |
| PTCT | PTC THERAPEUTICS, INC. | 05 Jan 2023 | 2 | $0 | 4 | Director | 09 Jan 2023, 15:14 |
| PTCT | PTC THERAPEUTICS, INC. | 09 Jun 2022 | 4 | $0 | 4 | Director | 10 Jun 2022, 16:08 |
| PTCT | PTC THERAPEUTICS, INC. | 08 Jun 2022 | 0 | $0 | 3 | Director | 10 Jun 2022, 16:07 |
| GRPH | Graphite Bio, Inc. | 01 Apr 2022 | 1 | $0 | 4 | Chief Financial Officer | 05 Apr 2022, 18:01 |
| GRPH | Graphite Bio, Inc. | 01 Apr 2022 | 0 | $0 | 3 | Chief Financial Officer | 05 Apr 2022, 17:57 |